These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36246047)

  • 1. Cognitive and behavioural but not motor impairment increases brain age in amyotrophic lateral sclerosis.
    Hermann A; Tarakdjian GN; Temp AGM; Kasper E; Machts J; Kaufmann J; Vielhaber S; Prudlo J; Cole JH; Teipel S; Dyrba M
    Brain Commun; 2022; 4(5):fcac239. PubMed ID: 36246047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive and behavioural impairment in amyotrophic lateral sclerosis: A landmark of the disease? A mini review of longitudinal studies.
    Consonni M; Dalla Bella E; Bersano E; Lauria G
    Neurosci Lett; 2021 May; 754():135898. PubMed ID: 33862143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gray matter and white matter changes in non-demented amyotrophic lateral sclerosis patients with or without cognitive impairment: A combined voxel-based morphometry and tract-based spatial statistics whole-brain analysis.
    Christidi F; Karavasilis E; Riederer F; Zalonis I; Ferentinos P; Velonakis G; Xirou S; Rentzos M; Argiropoulos G; Zouvelou V; Zambelis T; Athanasakos A; Toulas P; Vadikolias K; Efstathopoulos E; Kollias S; Karandreas N; Kelekis N; Evdokimidis I
    Brain Imaging Behav; 2018 Apr; 12(2):547-563. PubMed ID: 28425061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for cognitive and behavioural impairment in amyotrophic lateral sclerosis: Frequency of abnormality and effect on survival.
    Xu Z; Alruwaili ARS; Henderson RD; McCombe PA
    J Neurol Sci; 2017 May; 376():16-23. PubMed ID: 28431606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TDP-43 cytoplasmic inclusion formation is disrupted in
    Lee SM; Asress S; Hales CM; Gearing M; Vizcarra JC; Fournier CN; Gutman DA; Chin LS; Li L; Glass JD
    Brain Commun; 2019; 1(1):fcz014. PubMed ID: 31633109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebellar integrity in the amyotrophic lateral sclerosis-frontotemporal dementia continuum.
    Tan RH; Devenney E; Dobson-Stone C; Kwok JB; Hodges JR; Kiernan MC; Halliday GM; Hornberger M
    PLoS One; 2014; 9(8):e105632. PubMed ID: 25144223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis.
    Menke RA; Körner S; Filippini N; Douaud G; Knight S; Talbot K; Turner MR
    Brain; 2014 Sep; 137(Pt 9):2546-55. PubMed ID: 24951638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papez Circuit Gray Matter and Episodic Memory in Amyotrophic Lateral Sclerosis and Behavioural Variant Frontotemporal Dementia.
    Bueno APA; de Souza LC; Pinaya WHL; Teixeira AL; de Prado LGR; Caramelli P; Hornberger M; Sato JR
    Brain Imaging Behav; 2021 Apr; 15(2):996-1006. PubMed ID: 32734436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study.
    Byrne S; Elamin M; Bede P; Shatunov A; Walsh C; Corr B; Heverin M; Jordan N; Kenna K; Lynch C; McLaughlin RL; Iyer PM; O'Brien C; Phukan J; Wynne B; Bokde AL; Bradley DG; Pender N; Al-Chalabi A; Hardiman O
    Lancet Neurol; 2012 Mar; 11(3):232-40. PubMed ID: 22305801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72.
    Boeve BF; Boylan KB; Graff-Radford NR; DeJesus-Hernandez M; Knopman DS; Pedraza O; Vemuri P; Jones D; Lowe V; Murray ME; Dickson DW; Josephs KA; Rush BK; Machulda MM; Fields JA; Ferman TJ; Baker M; Rutherford NJ; Adamson J; Wszolek ZK; Adeli A; Savica R; Boot B; Kuntz KM; Gavrilova R; Reeves A; Whitwell J; Kantarci K; Jack CR; Parisi JE; Lucas JA; Petersen RC; Rademakers R
    Brain; 2012 Mar; 135(Pt 3):765-83. PubMed ID: 22366793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort.
    Van Mossevelde S; van der Zee J; Gijselinck I; Engelborghs S; Sieben A; Van Langenhove T; De Bleecker J; Baets J; Vandenbulcke M; Van Laere K; Ceyssens S; Van den Broeck M; Peeters K; Mattheijssens M; Cras P; Vandenberghe R; De Jonghe P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C;
    Brain; 2016 Feb; 139(Pt 2):452-67. PubMed ID: 26674655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.
    Hsiung GY; DeJesus-Hernandez M; Feldman HH; Sengdy P; Bouchard-Kerr P; Dwosh E; Butler R; Leung B; Fok A; Rutherford NJ; Baker M; Rademakers R; Mackenzie IR
    Brain; 2012 Mar; 135(Pt 3):709-22. PubMed ID: 22344582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
    Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
    Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72.
    Cooper-Knock J; Hewitt C; Highley JR; Brockington A; Milano A; Man S; Martindale J; Hartley J; Walsh T; Gelsthorpe C; Baxter L; Forster G; Fox M; Bury J; Mok K; McDermott CJ; Traynor BJ; Kirby J; Wharton SB; Ince PG; Hardy J; Shaw PJ
    Brain; 2012 Mar; 135(Pt 3):751-64. PubMed ID: 22366792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between neuropsychiatric disorders and cognitive and behavioural change in MND.
    McHutchison CA; Leighton DJ; McIntosh A; Cleary E; Warner J; Porteous M; Chandran S; Pal S; Abrahams S
    J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):245-253. PubMed ID: 31871139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical markers of cognitive syndromes in amyotrophic lateral sclerosis.
    Consonni M; Contarino VE; Catricalà E; Dalla Bella E; Pensato V; Gellera C; Lauria G; Cappa SF
    Neuroimage Clin; 2018; 19():675-682. PubMed ID: 30023173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
    Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
    Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients.
    Scialò C; Tran TH; Salzano G; Novi G; Caponnetto C; Chiò A; Calvo A; Canosa A; Moda F; Caroppo P; Silani V; Ticozzi N; Ratti A; Borroni B; Benussi L; Ghidoni R; Furlanis G; Manganotti P; Senigagliesi B; Parisse P; Brasselet R; Buratti E; Legname G
    Brain Commun; 2020; 2(2):fcaa142. PubMed ID: 33094285
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Manini A; Ratti A; Brusati A; Maranzano A; Fogh I; Peverelli S; Messina S; Gentilini D; Verde F; Poletti B; Morelli C; Silani V; Ticozzi N
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal imaging in
    Floeter MK; Bageac D; Danielian LE; Braun LE; Traynor BJ; Kwan JY
    Neuroimage Clin; 2016; 12():1035-1043. PubMed ID: 27995069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.